(Q67485899)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310409%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310409%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

The Anticollagenolytic Potential of Lymecycline in the Long‐Term Treatment of Reactive Arthritis (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

1 December 2023

1 reference

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

1 December 2023

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

1 December 2023

6

L M Golub

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310409%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

author name string

A. Lauhio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310409

11 September 2022

T. Sorsa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310409

11 September 2022

O. Lindy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310409

11 September 2022

K. Suomalainen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310409

11 September 2022

H. Saari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310409

11 September 2022

Y. T. Konttinen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310409

11 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1310409

11 September 2022

publication date

1 February 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310409%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 September 2019

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.1780350211

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310409

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780350211

1 December 2023

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.1780350211

1 December 2023

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

1 December 2023

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310409%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310409%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310409%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

195-198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310409%20AND%20SRC:MED&resulttype=core&format=json

Reactive arthritis associated with Shigella sonnei infection

14 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis

1 December 2023

2

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

Tissue destruction by neutrophils

1 December 2023

4

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

Tissue destruction by neutrophils

1 December 2023

5

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases

1 December 2023

6

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs

1 December 2023

7

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

Suppression of human neutrophil functions by tetracyclines

1 December 2023

8

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

Scavenging of hypochlorous acid by tetracycline, rifampicin and some other antibiotics: a possible antioxidant action of rifampicin and tetracycline?

1 December 2023

9

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

Human neutrophil collagenase cleaves alpha 1-antitrypsin

1 December 2023

12

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity

1 December 2023

13

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

Minocycline treatment for rheumatoid arthritis: an open dose finding study

1 December 2023

16

1 reference

https://api.crossref.org/works/10.1002/ART.1780350211

1 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310409%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference